Recombinant immunotoxins
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant immunotoxins, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment